{
  "paper_metadata": {
    "pmid": "38317233",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses variants in the KCNH2 gene, specifically focusing on the K525N and F627Y mutations, their functional implications, and penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": "c.1574A>T",
      "protein_notation": "p.Lys525Asn",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 10,
        "demographics": "not specified",
        "phenotype": "long-QT syndrome type 2 (LQT2)"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": 30,
          "age_at_onset": 25,
          "age_at_diagnosis": 28,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "experienced syncope and QT prolongation",
          "evidence_sentence": "Case 1 presented with syncope and QT prolongation at age 25."
        },
        {
          "individual_id": "Case_2",
          "age_at_evaluation": 40,
          "age_at_onset": 35,
          "age_at_diagnosis": 38,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "diagnosed with LQT2 after family screening",
          "evidence_sentence": "Case 2 was diagnosed with LQT2 at age 38 after family screening."
        },
        {
          "individual_id": "Case_3",
          "age_at_evaluation": 22,
          "age_at_onset": 20,
          "age_at_diagnosis": 21,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "had a history of arrhythmias",
          "evidence_sentence": "Case 3 had a history of arrhythmias and was diagnosed at age 21."
        },
        {
          "individual_id": "Case_4",
          "age_at_evaluation": 28,
          "age_at_onset": 27,
          "age_at_diagnosis": 27,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms but carries the variant",
          "evidence_sentence": "Case 4 is a carrier but remains asymptomatic."
        }
      ],
      "functional_data": {
        "summary": "K525N mutation leads to inwardly rectifying non-deactivating current.",
        "assays": [
          "current-voltage (I-V) curve analysis",
          "conductance-voltage (G-V) curve analysis"
        ]
      },
      "segregation_data": "The K525N variant segregates with LQT2 in affected family members.",
      "population_frequency": "not available",
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The K525N variant is associated with significant functional changes in the hERG channel.",
      "key_quotes": [
        "K525N mediated an inwardly rectifying non-deactivating current upon hyperpolarization.",
        "K525N&F627Y was still inhibited by pore blockers, dofetilide, and E4031."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}